Pharmacogenomics Market is Estimated to Witness High Growth Owing to Advances in Genomic Technologies

 
Pharmacogenomics Market

The pharmacogenomics market involves understanding how an individual's genetic inheritance affects his ability to respond to drugs. It combines pharmacology and genomics to develop effective, safe medication and drug dosage personalized to an individual's genetic makeup. Pharmacogenomics testing helps determine the most suitable drug, its dosage and duration to maximize effectiveness and minimize adverse reactions. 

The Global pharmacogenomics market is estimated to be valued at US$ 1.9 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the pharmacogenomics market are Daimler AG, Ford Motor Company, Renault SA, Ashok Leyland Ltd, VE Commercial Vehicles Limited, Tata Motors Ltd, SML Isuzu Limited, GM Group, Mahindra & Mahindra Ltd, Volkswagen AG, Toyota Motor Corporation and Stellantis NV. Key players like Daimler AG are focusing on developing genetic testing to personalize treatment for conditions like cancer and heart diseases.

The growing awareness about advantages of pPharmacogenomic Market Size testing in precision medicine offers significant opportunities for market players. Pharmacogenomics helps reduce trial and error in drug development and saves billions in drug development costs annually. Technological advancements like high-throughput sequencing and microarray analysis have accelerated pharmacogenomics research activities.

Market Drivers

The increasing geriatric population globally is one of the key drivers for the pharmacogenomics market. Older adults often have multiple chronic conditions requiring complex drug regimes. Pharmacogenomics helps reduce adverse side effects in elderly patients and improves drug efficacy. Secondly, the rising prevalence of lifestyle diseases like cancer, cardiovascular disorders and diabetes is also fueling market growth. Pharmacogenomics assays can help determine the most suitable medication and dosage to effectively treat such diseases based on a person's genetic profile.

Current challenges in Pharmacogenomics Market
The pharmacogenomics market is currently facing various challenges which need to be addressed for realizing its true potential. Lack of awareness about the benefits of pharmacogenomics among patients as well as physicians is a major roadblock. There are also concerns regarding legal and ethical issues involved in genetic testing and data privacy. Implementation of pharmacogenomic testing in clinical practice requires overcoming issues related to regulatory guidelines, reimbursement policies and clinical validation. High costs associated with genetic testing and need for specialized infrastructure and skilled workforce are other significant challenges.

SWOT Analysis
Strength: Rapid advancements in genomics and bioinformatics technologies. Growing focus on precision medicine approach.
Weakness: Lack of standardized guidelines and protocols. Ethical and legal concerns regarding genetic data privacy.
Opportunity: Scope for pharmacogenomic guided drug development. Potential to reduce adverse drug reactions and healthcare costs.
Threats: Issues related to regulatory approvals and reimbursement policies. Competition from alternative treatment options.

In terms of value, North America dominated the global pharmacogenomics market in 2023. This can be attributed to growing adoption of personalized medicine approach in the region along with widespread adoption of direct-to-consumer genetic testing. The Asia Pacific region is expected to be the fastest growing regional market during the forecast period from 2024 to 2030 fueled by increasing healthcare spending, rising awareness about genetic disorders and growing population. Countries like China, India and South Korea are likely to offer lucrative opportunities for market players in the coming years.

Get more insights on – Pharmacogenomics Market

Explore Related Articles- Bone Marrow Transplant Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

Comments

Post a Comment

Popular posts from this blog

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

Image
  Eyewear Market The global Eyewear Market is estimated to be valued at US$ 273.4 billion in 2018 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: The Eyewear Market includes products such as prescription glasses, contact lenses, and sunglasses. These products offer vision correction and protection from harmful ultraviolet (UV) rays. The increasing prevalence of eye disorders and the growing awareness about the importance of eye health are driving the demand for eyewear products. Furthermore, the rising use of digital devices and exposure to blue light is also contributing to the need for prescription eyewear to reduce eye strain and prevent vision problems. Market Key Trends: One key trend in the Eyewear Market is the increasing demand for fashionable and luxury eyewear. Consumers are not only seeking vision correction but also looking for eyewear that complements
Read more

The Mobile Computed Tomography Is The Fastest Growing Segment Fueling The Growth Of Computed Tomography Market

Image
  Computed Tomography Market The global Computed Tomography Market is estimated to be valued at US$ 7.9 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview : Computed tomography, commonly known as CT or CAT scan, is a medical imaging technique used for clinical diagnosis and interventional procedures. CT imaging provides cross-sectional views of the internal organs to accurately detect medical conditions such as cancer, blood clots, lung nodules, or bone fractures. CT scans generate three-dimensional images or slices of the bones, blood vessels, and soft tissues inside the body. Market key trends: One of the key trends in the computed tomography market is the growing adoption of mobile CT systems. Mobile CT systems are CT devices that can be transported to various locations within a hospital campus or healthcare facility. Mobile CT scanners provide versat
Read more

Electronic Warfare Market Poised to Witness High Growth Owing to Increasing Usage of EW Systems Across Military and Defense Sectors

Image
Electronic Warfare Market Electronic warfare (EW) systems are used for detecting, deceiving or damaging enemy’s communication and radar systems. It involves deliberate emission or suppression of electromagnetic energy to maintain information dominance. EW systems find wide applications across military, including land, sea, air and space operations for counteracting threats from armed forces of other nations. The need for situational awareness and gaining tactical advantage over opponents has catalyzed demand from armed forces globally. The global electronic warfare market is estimated to be valued at US$ 18.45 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031.  Key players operating in the electronic warfare market are BAE Systems plc, Elbit Systems Ltd., General Dynamics Corporation, Israel Aerospace Industries Ltd., L3Harris Technologies Inc., Leonardo SpA, Lockheed Martin Corporation, Northrop Grumman Corporation, Raytheon Technologies Corpor
Read more